ARC Desk

Anatomic Pathology Market Will Be Hit $ 24 Billion By 2026

Lehdistötiedote   •   Heinä 16, 2019 14:14 EEST

The global Anatomic Pathology Market Size is expected to reach 24 billion by 2026. The market is estimated to grow at a CAGR of 6.0% during the forecast period from 2019 to 2026.

Acumen Research and Consulting has recently published a research report on the Anatomic Pathology Market for the forecast period of 2019 to 2026, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Anatomic Pathology Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2026.

The research study on the Anatomic Pathology Market analyzes key drivers upholding product sales and prominent trends shaping the growth of the market. The research study not only focuses on the latent opportunities for the key stakeholders of the market, but also sheds light on the notable developments and future scope for innovation in the landscape.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1525

The report starts off with a quick executive summary, wherein, key takeaways have been highlighted for the readers to have a sneak peak at the key market segments. The research study by ARC on the market also talks about the macroeconomic and microeconomic factors having deep-rooted influences on global market growth. The research study on the Anatomic Pathology Market also offers a regional analysis, wherein, demand across every region has been comprehensively analyzed.

The report also analyzes the Anatomic Pathology Market on the basis of various segments, with drug type being a prominent one. A unique section in the report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred.

Market Segmentation

Market, By Product and Service

  • Consumables
    • Reagents & Antibodies
    • Probes & Kits
    • Others
  • Instruments
    • Tissue processors
    • Automatic Stainers
    • Microtomes & Cryostat
    • Others
  • Services

Market, By Application

  • Drug Discovery & Development
  • Disease Diagnosis
  • Others

Market, By End-use

  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories
  • Others

Market, By Geography

  • North America.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

The market research study on “Anatomic Pathology Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Anatomic Pathology market segments with market dynamics and their impact. The report also covers basic technology development policies.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

What is the overall structure of the market?

What was the historical value and what is the forecasted value of the market?

What are the key product level trends in the market?

What are the market level trends in the market?

Which of the market players are leading and what are their key differential strategies to retain their stronghold?

Which are the most lucrative regions in the market space?

Buy this Premium Research Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1525

Research Methodology

The report on the Anatomic Pathology Market is based on an extensive and meticulous bottom up approach, which was used to determine the market size.

In the primary phase of the research methodology focus on, key stakeholders, including CEOs, presidents, vice presidents, chief medical officers, and product/sales/marketing managers were interviewed for the purpose of garnering unique insights into the dynamics of the market.

Market Participants:

Some of the key players are Laboratory Corporation of America Holdings; Thermo Fisher Scientific, Inc.; Sakura Finetek USA, Inc.Cardinal Health, Inc.; Agilent Technologies, Inc.; F. Hoffmann-La Roche AG; Quest Diagnostics Incorporated; BioGenex; NeoGenomics Laboratories, Inc.; and Bio SB.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Anatomic Pathology
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Anatomic Pathology Market By Product and Service
1.2.2.1. Global Anatomic Pathology Market Revenue and Growth Rate Comparison By Product and Service (2015-2026)
1.2.2.2. Global Anatomic Pathology Market Revenue Share By Product and Service in 2017
1.2.2.3. Consumables
1.2.2.3.1. Reagents & Antibodies
1.2.2.3.2. Probes & Kits
1.2.2.3.3. Others
1.2.2.4. Instruments
1.2.2.4.1. Tissue processors
1.2.2.4.2. Automatic Stainers
1.2.2.4.3. Microtomes & Cryostat
1.2.2.4.4. Others
1.2.2.5. Services
1.2.3. Anatomic Pathology Market By Application
1.2.3.1. Global Anatomic Pathology Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Drug Discovery & Development
1.2.3.3. Disease Diagnosis
1.2.3.4. Others
1.2.4. Anatomic Pathology Market By End-use
1.2.4.1. Global Anatomic Pathology Market Revenue and Growth Rate Comparison By End-use (2015-2026)
1.2.4.2. Hospitals
1.2.4.3. Diagnostic Laboratories
1.2.4.4. Research Laboratories
1.2.4.5. Others
1.2.5. Anatomic Pathology Market by Geography
1.2.5.1. Global Anatomic Pathology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Anatomic Pathology Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Anatomic Pathology Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Anatomic Pathology Major Manufacturers in 2017
3.3. R&D Status and Technology Product and Service of Global Anatomic Pathology Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Anatomic Pathology Major Manufacturers in 2017

CHAPTER 4. ANATOMIC PATHOLOGY MARKET BY PRODUCT AND SERVICE

4.1. Global Anatomic Pathology Revenue By Product and Service
4.2. Consumables
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Reagents & Antibodies
4.2.4. Probes & Kits
4.2.5. Others
4.3. Instruments
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. Tissue processors
4.3.4. Automatic Stainers
4.3.5. Microtomes & Cryostat
4.3.6. Others
4.4. Services
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ANATOMIC PATHOLOGY MARKET BY APPLICATION

5.1. Global Anatomic Pathology Revenue By Application
5.2. Drug Discovery & Development
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Disease Diagnosis
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. ANATOMIC PATHOLOGY MARKET BY END-USE

6.1. Global Anatomic Pathology Revenue By End-use
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Diagnostic Laboratories
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Research Laboratories
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA ANATOMIC PATHOLOGY MARKET BY COUNTRY

7.1. North America Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Anatomic Pathology Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Anatomic Pathology Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE ANATOMIC PATHOLOGY MARKET BY COUNTRY

8.1. Europe Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Anatomic Pathology Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET BY COUNTRY

9.1. Asia-Pacific Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Anatomic Pathology Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA ANATOMIC PATHOLOGY MARKET BY COUNTRY

10.1. Latin America Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Anatomic Pathology Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST ANATOMIC PATHOLOGY MARKET BY COUNTRY

11.1. Middle East Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Anatomic Pathology Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA ANATOMIC PATHOLOGY MARKET BY COUNTRY

12.1. Africa Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Anatomic Pathology Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Boehringer Ingelheim GmbH
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Lonza
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Rentschler Biotechnologie GmbH
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. JRS Pharma (Celonic GmbH)
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. TOYOBO Biologics, LTD
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. FUJIFILM Diosynth Biotechnologies U.S.A.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Patheon
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. CMC Biologics
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. WuXi Biologics
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1525

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.